You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
錦欣生殖(01951.HK)擬在老撾設立獲許可進行IVF的新醫學中心
格隆匯 03-03 21:45

格隆匯3月3日丨錦欣生殖(01951.HK)發佈公告,為擴展在老撾的業務,公司間接全資附屬公司JXR New Hope Limited已於2020年2月29同意自獨立第三方瑞亞國際醫學中心(“瑞亞”)收購相關經營許可,以在老撾提供輔助生殖服務及經營IVF(體外受精)醫學中心。

公司計劃於老撾的磨丁經濟特區內設立一間獲許可進行IVF的新醫學中心,而建築面積約為5,000平方米的新醫學中心預期於2020年第三季度開業,並預計具有每年進行超過3,000個IVF治療週期的能力。

自收購相關經營許可起至新醫學中心開業止的期間,公司將通過合作安排由瑞亞現有的醫學中心為患者提供服務。新醫學中心將預期提供多項服務,包括IVF-ET(體外受精及胚胎移植)、ICSI(卵細胞漿內單精子注射)、PGS(植入前基因篩查)╱PGD(植入前遺傳學診斷)、第三方IVF、各種IVF技術及治療選擇以及卵子及精子冷凍保存。新醫學中心位於磨丁經濟特區的邊境附近,毗鄰中國,並將可從雲南省昆明以約四個小時車程通過作為一帶一路戰略一部分及將於2021年竣工的高鐵抵達。

公告表示,公司董事相信,在老撾的業務擴展將使公司能夠通過開拓東南亞市場進一步擴大其全球影響力,並以更廣泛的服務選擇及更低價格為中國的患者提供其他海外選擇,而此符合公司拓展至中國以外的國際化戰略,並迎合來自中國市場的大量患者流量。

此外,公司已致力並將繼續通過擴大其網絡以實施其業務戰略,以解決中國患者不斷的需求,併為股東創造長期價值。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account